CLINICAL_TRIALS
trial_result
· 2024-06-04
Clinical Trial Update: Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients [Phase 2]
Summary
Phase 2 efficacy trial update for oral sapacitabine in elderly patients with acute myeloid leukemia; results were posted on 2024-06-04.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cyclacel Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-06-04